We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.05B
AUM Growth
-$68.1M
Cap. Flow
-$92.6M
Cap. Flow %
-8.82%
Top 10 Hldgs %
22.12%
Holding
2,122
New
405
Increased
518
Reduced
436
Closed
484

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Financials 12.43%
3 Healthcare 9.96%
4 Industrials 9.86%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTNB icon
1526
Matinas BioPharma
MTNB
$1.69M
$1K ﹤0.01%
+13
New +$1.75K
MUR icon
1527
Murphy Oil
MUR
$4.88B
$1K ﹤0.01%
35
NBR icon
1528
Nabors Industries
NBR
$1.23B
$1K ﹤0.01%
2
-1,063
-100% -$535K
NC icon
1529
NACCO Industries
NC
$318M
$1K ﹤0.01%
44
-87
-66% -$1.45K
NDLS icon
1530
Noodles & Co
NDLS
$109M
$1K ﹤0.01%
41
-6
-13% -$234
NNBR icon
1531
NN Inc
NNBR
$302M
$1K ﹤0.01%
+26
New +$720
NOG icon
1532
Northern Oil and Gas
NOG
$2.35B
$1K ﹤0.01%
53
+7
+15% +$135
NPK icon
1533
National Presto Industries
NPK
$985M
$1K ﹤0.01%
12
NSA
1534
DELISTED
National Storage Affiliates Trust
NSA
$1K ﹤0.01%
63
OPCH icon
1535
Option Care Health
OPCH
$3.59B
$1K ﹤0.01%
68
-144
-68% -$1.09K
PHX
1536
DELISTED
PHX Minerals
PHX
$1K ﹤0.01%
38
+10
+36% +$203
PLUG icon
1537
Plug Power
PLUG
$3.03B
$1K ﹤0.01%
691
-1,102
-61% -$2.31K
POWL icon
1538
Powell Industries
POWL
$7.74B
$1K ﹤0.01%
+72
New +$800
PTCT icon
1539
PTC Therapeutics
PTCT
$6.02B
$1K ﹤0.01%
49
-109
-69% -$1.47K
PTGX icon
1540
Protagonist Therapeutics
PTGX
$9.4B
$1K ﹤0.01%
79
+25
+46% +$267
RCKT icon
1541
Rocket Pharmaceuticals
RCKT
$380M
$1K ﹤0.01%
158
RCL icon
1542
Royal Caribbean
RCL
$85.5B
$1K ﹤0.01%
7
RDI icon
1543
Reading International Class A
RDI
$34.5M
$1K ﹤0.01%
46
-1
-2% -$16
RDNT icon
1544
RadNet
RDNT
$5.51B
$1K ﹤0.01%
190
RGLS
1545
DELISTED
Regulus Therapeutics
RGLS
$1K ﹤0.01%
12
SIVR icon
1546
abrdn Physical Silver Shares ETF
SIVR
$4.39B
$1K ﹤0.01%
70
DCOY
1547
Decoy Therapeutics
DCOY
$2.09M
0
SLS icon
1548
SELLAS Life Sciences
SLS
$2.35B
$1K ﹤0.01%
1
SMBC icon
1549
Southern Missouri Bancorp
SMBC
$850M
$1K ﹤0.01%
27
SRCE icon
1550
1st Source
SRCE
$2.13B
$1K ﹤0.01%
30

Similar funds

Meeder Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Meeder Asset Management held 2,122 positions worth $1.05B, down 6.1% from $1.12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Meeder Asset Management withdrew a net $92.6M in Q2 2017, closing 484 positions and reducing 436 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Humana worth $5.43M.

  • Meeder Asset Management's largest Q2 2017 buy was Humana: 22,582 shares worth $5.43M.
  • Meeder Asset Management added most to State Street SPDR Bloomberg High Yield Bond ETF in Q2 2017, an estimated $23.9M increase.
  • Meeder Asset Management's biggest Q2 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $41.8M.
  • Meeder Asset Management fully exited iShares 20+ Year Treasury Bond ETF in Q2 2017, selling an estimated $13M.
  • Meeder Asset Management's ten largest holdings make up 22% of its $1.05B portfolio in Q2 2017.
  • Meeder Asset Management opened 405 new positions and closed 484 in Q2 2017.
  • Meeder Asset Management's portfolio value fell 6.1% quarter-over-quarter to $1.05B.

Based on Meeder Asset Management's 13F filing for Q2 2017, filed 13 Jul 2017.